Results 111 to 120 of about 2,239,240 (303)
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Investigation and analysis of allergen labeling in prepackaged food in China
ObjectiveTo investigate the current status of allergen labeling in prepackaged food products in China.MethodsA total of 986 prepackaged foods in 18 categories were from 26 provinces (autonomous regions, centrally administered municipalities) randomly ...
WANG Dan +7 more
doaj +1 more source
Pathways through youth justice supervision: further analyses [PDF]
The youth justice system manages children and young people who have committed, or allegedly committed, an offence. In Australia, youth justice is the responsibility of the states and territories, and each has its own legislation, policies and practices ...
Kirsten Morgan +2 more
core
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou +12 more
wiley +1 more source
Efficient urinary stone type prediction: a novel approach based on self-distillation
Urolithiasis is a leading urological disorder where accurate preoperative identification of stone types is critical for effective treatment. Deep learning has shown promise in classifying urolithiasis from CT images, yet faces challenges with model size ...
Kun Liu +10 more
doaj +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source

